Nearly three-quarters of patients in Europe are willing to share their health data if it means receiving more personalised care, according to recent research from Johnson & Johnson MedTech.
As trade tensions with the US intensify, Beijing is transforming its pharma and med tech sectors, which only a few years ago were viewed as a relatively open and investment-friendly, into a strategic arena for self-reliance and technological control. This shift is not just reactive, it is a deliberate move and one that may end up reshaping the rules of global healthcare investment.
Last week, HBI sat down with Chris Meier, Managing Director and Partner at Boston Consulting Group (BCG), an American global management consulting firm, to explore how AI is transforming drug discovery. Bringing a new drug to market typically takes 12 to 15 years and costs upwards of $2.5 billion, with only a small percentage making […]
A few weeks ago, I went to check out four Korean medtech startups in central London demonstrating their innovative solutions amid the UK’s growing senior healthcare crisis. Each startup addressed a challenge in elderly care, including fall prevention (with prevention being called for more generally in the UK health system too), medication adherence, dementia diagnosis, and air quality monitoring.
A week after the conclusion of HBI 2025, which marked the inaugural shift of cities to Paris after fifteen years in London, we returned to the city to attend the 2025 Health and Life Science Symposium hosted by McDermott Will & Emery. 300 Investors, Biotech, Pharma, MedTech and TechBio execs gathered to discuss emerging […]
HBI’s annual conference took place last week and we’re still enjoying the highlights. The event was HBI’s Paris debut – after 15 years in London! It brought in nearly 900 delegates from 500 companies and 44 countries, with more than 120 investment firms and over 150 healthcare providers.
HBI 2025 is just around the corner. What are you most looking forward to? We asked our 2025 delegates — spanning healthcare providers, advisors, investors, and suppliers – to find out.
We are soon to release our 2025 Healthcare Property Report. Last year we released our first Special Report on Europe’s healthcare real estate market. This year’s report is structured similarly to last year’s, covering the latest market developments and deep dives into different sub sectors, but at roughly double the length of last year’s, it is substantially more indepth and features more case study interviews with specialist healthcare real estate investors.
There’s a palpable sense of purpose within the HBI team, who I can report are relishing the prospect of hosting the industry we serve in Paris for the very first time later this month. If you’re reading this and haven’t yet got your ticket, it’s not too late to book now. Please join us for […]
With the Christian Democratic Union and its Bavarian sister party (CDU/CSU) securing 28.6% of the vote and Friedrich Merz appearing likely — although by no means certain — to form a coalition with the previous lead party of government the Social Democratic Party of Germany (SPD), there are signs that healthcare investors and providers can […]
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
